Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00733668
What this trial is testing

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca
Post-approval studies (Phase 4)Study completedNCT00159120
What this trial is testing

Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

Who this might be right for
SchizophreniaPsychoses
Heinrich-Heine University, Duesseldorf 71
Not applicableStudy completedNCT01043250
What this trial is testing

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Who this might be right for
SchizophreniaSchizoaffective Disorder
Samsung Medical Center 81
Testing effectiveness (Phase 2)Study completedNCT00167310
What this trial is testing

Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

Who this might be right for
SchizophreniaSchizoaffective DisorderMajor Depression+2 more
University of Pittsburgh 57
Not applicableStudy completedNCT01376492
What this trial is testing

FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 709
Large-scale testing (Phase 3)Study completedNCT00000371
What this trial is testing

Trial of D-Cycloserine in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 60
Not applicableStudy completedNCT00389493
What this trial is testing

Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder

Who this might be right for
Obsessive-Compulsive Disorder
New York State Psychiatric Institute 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06754163
What this trial is testing

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Who this might be right for
Obesity and Obesity-related Medical ConditionsPsychiatric Disorders
St Andrew's Healthcare 20
Post-approval studies (Phase 4)Study completedNCT01778244
What this trial is testing

Metformin for Treatment of Antipsychotic-induced Dyslipidemia

Who this might be right for
Dyslipidemia
Central South University 162
Not applicableStudy completedNCT00312598
What this trial is testing

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
University of North Carolina, Chapel Hill 30
Not applicableStudy completedNCT03557593
What this trial is testing

Optimizing Prescribing of Antipsychotics in Long-Term Care

Who this might be right for
Dementia
Queen's University
Not applicableStudy completedNCT00207064
What this trial is testing

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 46
Large-scale testing (Phase 3)Looking for participantsNCT05431595
What this trial is testing

Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

Who this might be right for
DeliriumEpilepticsNeuroleptics
M.D. Anderson Cancer Center 42
Early research (Phase 1)Study completedNCT05857566
What this trial is testing

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Who this might be right for
Drug-induced Weight Gain
Response Pharmaceuticals 24
Not applicableStudy completedNCT00833456
What this trial is testing

NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 106
Large-scale testing (Phase 3)Study completedNCT00216580
What this trial is testing

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

Who this might be right for
Schizophrenia
Janssen Pharmaceutica N.V., Belgium 50
Testing effectiveness (Phase 2)UnknownNCT04224441
What this trial is testing

Repurposing Chlorpromazine in the Treatment of Glioblastoma

Who this might be right for
Glioblastoma MultiformeMGMT-Unmethylated Glioblastoma
Marco G Paggi, MD, PhD 41
Not applicableStudy completedNCT02573168
What this trial is testing

Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective Disorder
St. Joseph's Healthcare Hamilton 103
Not applicableStudy completedNCT00515723
What this trial is testing

Glucose and Lipid Metabolism on Antipsychotic Medication

Who this might be right for
SchizophreniaSchizoaffective DisorderType 2 Diabetes Mellitus+1 more
Washington University School of Medicine 96
Not applicableUnknownNCT06107322
What this trial is testing

Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors

Who this might be right for
Neutropenia
University Hospital, Strasbourg, France 20
Next Page